Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC2362 Gsk207040
Novel selective non-imidazole histamine H 3 receptor antagonist
More description
DCC2361 Gsk2008607
Novel competitive inhibitor of rTbIPMK with respect to Ins(1,4,5)P3
More description
DCC2360 Gsk1997132b
Novel potent, metabolically stable and centrally penetrant PPARγ partial agonist
More description
DCC2359 Gsk1910364
Novel inhibitor of EPHX2 (epoxide hydrolase 2, alias soluble epoxide hydrolase or sEH), up-regulating cytoprotective genes and down-regulating proinflammatory cytokine production
More description
DCC2358 Gsk189254
Potent and selective H3 histamine receptor inverse agonist
More description
DCC2357 Gsk1829820a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2355 Gsk1723980
Novel noncompetitive inhibitor of rTbIPMK
More description
DCC2354 Gsk1452498a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2353 Gsk1452496a
Potent non-cytotoxic inhinitor of Mycobacterium tuberculosis H37Rv
More description
DCC2352 Gsk1379767a
Novel dual inhibitor of BPTF and Brd4
More description
DCC2351 Gsk1370319a
Novel specific P2X(7) receptor antagonist
More description
DCC2350 (BrMT)2
Non-peptidic snail toxin; Activator of the Kv1.1 potassium ion channel
More description
DCC2349 Gsk-1264
Novel allosteric inhibitor of human immunodeficiency virus (HIV) integrase, blocking viral replication and abnormal multimerization involving specific protein domains
More description
DCC2348 Gsk1180781a
Novel selective inhibitor of MmpL3 mutation
More description
DCC2347 Gsk1104252a
Potent and selective GPR119 agonist
More description
DCC2346 Gsk1030058a
Novel inhibitor of polo-like kinase
More description
DCC2345 Gsk1023156a
Novel inhibitor of polo-like kinase
More description
DCC2344 Gsk1007102b Tfa Salt
Potent inhibitor of AKT kinase, showing activity against auxotrophic M. tuberculosis and being potentiated with meropenem
More description
DCC2343 Gsk-1004723
Novel dual H1 and H3 receptor antagonist with a long duration of action
More description
DCC2342 Gsk1000163a
Potent inhibitor of AKT kinase
More description
DCC2341 Gsk059a
Novel potent EchA6 inhibitor
More description
DCC2340 Gsk002
Novel allosteric HIV-1 integrase (IN) inhibitor, disrupting formation of mature HIV particles
More description
DCC2339 gsh-mem
Glutamate receptor antagonist and radical scavenging agent
More description
DCC2338 Gsa-0902
Novel high potent and selective stabilizer of the MYC G-quadruplex (G4)
More description
DCC2337 Gs-8374
Potent and selective inhibitor of HIV-1 protease, effectively inhibiting protease mutants with amino acid insertions, also inhibiting major aspartyl peptidase 1 (May1), a secreted Cryptococcus neoformans protease
More description
DCC2336 Gs-621763
Novel oral prodrug of GS-441524, inhibiting SARS-CoV-2, including variants of concern (VOC) in cell culture and human airway epithelium organoids
More description
DCC2335 Gs-563253
Novel Inhibitor of Hepatitis C Viral Infectivity
More description
DCC2334 Gs-441524 Triphosphate (gs-443902 Sodium)
Novel potent inhibitor of feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
More description
DCC2333 Grp-156784
Novel allosteric inhibitor of respiratory syncytial virus (RSV)
More description
DCC2332 Grl-8234
Novel β-Secretase BACE1 Inhibitor, reversing memory impairments and rescuing age-related cognitive decline
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X